(Total Views: 2847)
Posted On: 05/12/2017 7:45:30 PM
Post# of 1525
Market cap of a company in this sector (Drugs/Pharmaceutical) easily reaches 4x the P/S ratio...so for 22M revs in 2017 the RXMD pps fair market value, not even taking its constant market expansion into account, should be around 26+ cents .
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
With its current market cap of just 6M RXMD is 15xfold undervalued compared to hundreds of listed companies in this sector.
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
With its current market cap of just 6M RXMD is 15xfold undervalued compared to hundreds of listed companies in this sector.
(0)
(0)
